Genpharmasec Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 329838,
    "name": "Genpharmasec",
    "stock_name": "Genpharmasec",
    "full_name": "Genpharmasec Ltd",
    "name_url": "stocks-analysis/genpharmasec",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.15",
    "chg": 0.02,
    "chgp": "1.77%",
    "dir": 1,
    "prev_price": "1.13",
    "mcapval": "63.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531592,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE861N01036",
    "curr_date": "Apr 17",
    "curr_time": "",
    "bse_nse_vol": "3.81 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 17, 2026",
    "traded_date_str": "2026 04 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genpharmasec-329838-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3944707",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GenpharmasecLtd_mojoScore_3944707.png",
        "date": "2026-04-13 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3930273",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GenpharmasecLtd_mojoScore_3930273.png",
        "date": "2026-04-02 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 April 2026, providing investors with the latest comprehensive view of the company’s position."
      },
      {
        "title": "Genpharmasec Ltd Falls to 52-Week Low of Rs 0.79 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-ltd-stock-hits-52-week-low-amid-continued-downtrend-3924228",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GenpharmasecLtd_priceRelatedfactors_3924228.png",
        "date": "2026-03-30 10:21:06",
        "description": "For the second consecutive session, Genpharmasec Ltd has extended its decline, hitting a fresh 52-week low of Rs 0.79 on 30 Mar 2026, marking a 12.09% drop over two days amid broader market weakness."
      },
      {
        "title": "Genpharmasec Ltd Falls to 52-Week Low of Rs 0.88 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-ltd-stock-hits-52-week-low-amidst-weak-market-performance-3919187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GenpharmasecLtd_priceRelatedfactors_3919187.png",
        "date": "2026-03-27 10:59:29",
        "description": ""
      },
      {
        "title": "Genpharmasec Ltd Falls to 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-ltd-falls-to-52-week-low-amid-continued-downtrend-3900586",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GenpharmasecLtd_priceRelatedfactors_3900586.png",
        "date": "2026-03-19 13:35:53",
        "description": "Genpharmasec Ltd, a micro-cap player in the Trading & Distributors sector, has touched a new 52-week and all-time low of Rs.0.89 on 19 Mar 2026, marking a significant decline amid broader market weakness and sector underperformance."
      },
      {
        "title": "Genpharmasec Ltd Stock Falls to 52-Week Low of Rs.0.91",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-ltd-stock-falls-to-52-week-low-of-rs091-3899016",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GenpharmasecLtd_priceRelatedfactors_3899016.png",
        "date": "2026-03-18 15:35:18",
        "description": "Genpharmasec Ltd, a micro-cap player in the Trading & Distributors sector, has recorded a fresh 52-week and all-time low of Rs.0.91 today, marking a significant milestone in its ongoing price decline. The stock has underperformed its sector and benchmark indices, reflecting persistent challenges in its financial and market performance."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3896318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GenpharmasecLtd_mojoScore_3896318.png",
        "date": "2026-03-17 10:10:17",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025, but the analysis below reflects the stock's current position as of 17 March 2026, incorporating the latest fundamentals, returns, and financial metrics."
      },
      {
        "title": "Genpharmasec Ltd Stock Falls to 52-Week Low of Rs.0.94",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-ltd-stock-falls-to-52-week-low-of-rs094-3887269",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GenpharmasecLtd_priceRelatedfactors_3887269.png",
        "date": "2026-03-12 15:42:03",
        "description": "Genpharmasec Ltd’s share price declined sharply to a new 52-week low of Rs.0.94 on 12 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This fresh low reflects persistent pressures on the company’s valuation amid broader market weakness and company-specific financial factors."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-3869015",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GenpharmasecLtd_mojoScore_3869015.png",
        "date": "2026-03-04 10:10:02",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 March 2026, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 5426,
    "sid": "329838",
    "stock_news_url": "https://www.marketsmojo.com/news/genpharmasec-329838"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "14-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Genpharmasec Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24231MH1992PLC323914</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Hardik Makwana <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: compliance@genpharmasec.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Mr Sohan Chaturvedi <br/> Designation: Chief Financial Officer <br/> EmailId: Sohan.chaturvedi@genpharmasec.com</div> </div> <div> <br/> Date: 14/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Intimation of closure of Trading window.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Apr 19",
          "dt": "2019-04-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:1</strong> rights issue, ex-date: 09 Jan 24",
          "dt": "2024-01-09",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Genpharmasec Ltd is Rated Strong Sell

2026-04-13 10:10:03

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-04-02 10:10:03

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 April 2026, providing investors with the latest comprehensive view of the company’s position.

Read full news article

Genpharmasec Ltd Falls to 52-Week Low of Rs 0.79 as Sell-Off Deepens

2026-03-30 10:21:06

For the second consecutive session, Genpharmasec Ltd has extended its decline, hitting a fresh 52-week low of Rs 0.79 on 30 Mar 2026, marking a 12.09% drop over two days amid broader market weakness.

Read full news article

Genpharmasec Ltd Falls to 52-Week Low of Rs 0.88 as Sell-Off Deepens

2026-03-27 10:59:29

Read full news article

Genpharmasec Ltd Falls to 52-Week Low Amid Continued Downtrend

2026-03-19 13:35:53

Genpharmasec Ltd, a micro-cap player in the Trading & Distributors sector, has touched a new 52-week and all-time low of Rs.0.89 on 19 Mar 2026, marking a significant decline amid broader market weakness and sector underperformance.

Read full news article

Genpharmasec Ltd Stock Falls to 52-Week Low of Rs.0.91

2026-03-18 15:35:18

Genpharmasec Ltd, a micro-cap player in the Trading & Distributors sector, has recorded a fresh 52-week and all-time low of Rs.0.91 today, marking a significant milestone in its ongoing price decline. The stock has underperformed its sector and benchmark indices, reflecting persistent challenges in its financial and market performance.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-03-17 10:10:17

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025, but the analysis below reflects the stock's current position as of 17 March 2026, incorporating the latest fundamentals, returns, and financial metrics.

Read full news article

Genpharmasec Ltd Stock Falls to 52-Week Low of Rs.0.94

2026-03-12 15:42:03

Genpharmasec Ltd’s share price declined sharply to a new 52-week low of Rs.0.94 on 12 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This fresh low reflects persistent pressures on the company’s valuation amid broader market weakness and company-specific financial factors.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-03-04 10:10:02

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

View All News

Announcement

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

14-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No.	Particulars	Details
1	Name of Company	Genpharmasec Ltd
2	CIN NO.	L24231MH1992PLC323914
3	Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)	0.00
4	Highest Credit Rating during the previous FY	NA
4a	Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)	Not Applicable
5	Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework	BSE

We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No

Name of the Company Secretary: Hardik Makwana
Designation: Company Secretary and Compliance Officer
EmailId: compliance@genpharmasec.com

Name of the Chief Financial Officer: Mr Sohan Chaturvedi
Designation: Chief Financial Officer
EmailId: Sohan.chaturvedi@genpharmasec.com

Date: 14/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.